Stephen L. Archer

46.4k total citations · 14 hit papers
306 papers, 33.5k citations indexed

About

Stephen L. Archer is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Stephen L. Archer has authored 306 papers receiving a total of 33.5k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Pulmonary and Respiratory Medicine, 114 papers in Cardiology and Cardiovascular Medicine and 89 papers in Molecular Biology. Recurrent topics in Stephen L. Archer's work include Pulmonary Hypertension Research and Treatments (147 papers), Nitric Oxide and Endothelin Effects (71 papers) and Mitochondrial Function and Pathology (38 papers). Stephen L. Archer is often cited by papers focused on Pulmonary Hypertension Research and Treatments (147 papers), Nitric Oxide and Endothelin Effects (71 papers) and Mitochondrial Function and Pathology (38 papers). Stephen L. Archer collaborates with scholars based in United States, Canada and United Kingdom. Stephen L. Archer's co-authors include Ε. Kenneth Weir, Evangelos D. Michelakis, John Ryan, Thenappan Thenappan, Kyoko Hashimoto, Václav Hampl, Stuart Rich, Rohit Moudgil, Sébastien Bonnet and Alois Haromy and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Stephen L. Archer

301 papers receiving 32.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

2009 1.8k citations Vallerie V. McLaughlin, Stephen L. Archer et al. profile →
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

2011 1.5k citations Stephen L. Archer et al. Circulation profile →
Cellular and molecular pathobiology of pulmonary arterial hypertension

2004 1.2k citations Marc Humbert, Stephen L. Archer et al. profile →
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth

2007 1.2k citations Sébastien Bonnet, Stephen L. Archer et al. profile →
Mitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases

2013 869 citations Stephen L. Archer New England Journal of Medicine profile →
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

2009 844 citations Vallerie V. McLaughlin, Stephen L. Archer et al. Circulation profile →
Measurement of nitric oxide in biological models

1993 773 citations Stephen L. Archer profile →
Pulmonary arterial hypertension: pathogenesis and clinical management

2018 676 citations Thenappan Thenappan, Mark L. Ormiston et al. profile →
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

1994 658 citations Stephen L. Archer, Ε. Kenneth Weir et al. Proceedings of the National Academy of Sciences profile →
Cellular and Molecular Basis of Pulmonary Arterial Hypertension

2009 640 citations Stephen L. Archer, Ε. Kenneth Weir et al. profile →
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension

2013 419 citations Stephen L. Archer, Evangelos D. Michelakis et al. profile →
The Right Ventricle in Pulmonary Arterial Hypertension

2014 339 citations John Ryan, Stephen L. Archer Circulation Research profile →
Hypoxic Pulmonary Vasoconstriction

2016 328 citations Kimberly J. Dunham‐Snary, Danchen Wu et al. profile →
Pulmonary hypertension

2024 132 citations Marc Humbert, Stephen L. Archer et al. profile →

Peers

Countries citing papers authored by Stephen L. Archer

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Archer more than expected).

Fields of papers citing papers by Stephen L. Archer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Archer. The network helps show where Stephen L. Archer may publish in the future.

Co-authorship network of co-authors of Stephen L. Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Archer. A scholar is included among the top collaborators of Stephen L. Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Archer. Stephen L. Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circular RNA Profiling Identifies circ5078 as a BMPR2 -Derived Regulator of Endothelial Proliferation and Stress Responses 2025 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), (unknown), Patrick Thompson, (unknown), (unknown), Jeffrey Mewburn, (unknown), Kimberly J. Dunham‐Snary, Anna R. Hemnes, Joy D. Cogan, Eric D. Austin, Rizwan Hamid, Stephen L. Archer, Neil Renwick, Mark L. Ormiston	1
2	Electron Leak From the Mitochondrial Electron Transport Chain Complex I at Site I _Q Is Crucial for Oxygen Sensing in Rabbit and Human Ductus Arteriosus 2023 ·Journal of the American Heart Association ·Austin Read, R. E. Bentley, Ashley Martin, Jeffrey Mewburn, Elahe Alizadeh, Danchen Wu, Patrícia Lima, Kimberly J. Dunham‐Snary, Bernard Thébaud, Willard W. Sharp, Stephen L. Archer	7
3	Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension 2022 ·American Journal of Respiratory and Critical Care Medicine ·Ruaa Al‐Qazazi, Patrícia Lima, Sasha Z. Prisco, François Potus, Asish Dasgupta, Kuang‐Hueih Chen, Lian Tian, R. E. Bentley, Jeff Mewburn, Ashley Martin, Danchen Wu, Oliver W. Jones, Donald H. Maurice, Sébastien Bonnet, Steeve Provencher, Kurt W. Prins, Stephen L. Archer	98
4	The comprehensive transcriptome of human ductus arteriosus smooth muscle cells (hDASMC) 2021 ·SHILAP Revista de lepidopterología ·R. E. Bentley, Charles C.T. Hindmarch, Kimberly J. Dunham‐Snary, Brooke Snetsinger, Jeffrey Mewburn, (unknown), Patrícia Lima, Bernard Thébaud, Stephen L. Archer	1
5	Home Virtual Visits for Outpatient Follow-Up Stroke Care: Cross-Sectional Study 2019 ·Journal of Medical Internet Research ·Ramana Appireddy, (unknown), Chad Leaver, (unknown), Albert Jin, Bryce A. Durafourt, Stephen L. Archer	49
6	Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide 2018 ·The Journal of Heart and Lung Transplantation ·Lauren Rose, Kurt W. Prins, Stephen L. Archer, Marc Pritzker, Ε. Kenneth Weir, Jeffrey R. Misialek, Thenappan Thenappan	47
7	Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension 2014 ·Circulation ·Anna R. Hemnes, Aaron W. Trammell, Stephen L. Archer, Stuart Rich, Chang Yu, Hui Nian, Niki Penner, (unknown), Lisa Wheeler, Ivan M. Robbins, Eric D. Austin, John H. Newman, James West	59
8	Mitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases breakdown → 2013 ·New England Journal of Medicine ·Stephen L. Archer	869
9	Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension 2012 ·Circulation Research ·Glenn Marsboom, Péter T. Tóth, John Ryan, Zhigang Hong, Xi‐Chen Wu, Yong-Hu Fang, Thenappan Thenappan, Lin Piao, Hannah J. Zhang, Jennifer Pogoriler, Yimei Chen, Erik Morrow, Ε. Kenneth Weir, Jalees Rehman, Stephen L. Archer	387
10	Myocardial Damage in Patients with Sarcoidosis and Preserved Left Ventricular Systolic Function: An Observational Study 2011 ·European Journal of Heart Failure ·Amit R. Patel, (unknown), Sonal Chandra, Kirk T. Spencer, Jeanne M. DeCara, Roberto M. Lang, Martin C. Burke, Edward R. Garrity, D. Kyle Hogarth, Stephen L. Archer, Nadera Sweiss, John F. Beshai	79
11	Antenatal Sildenafil Treatment Attenuates Pulmonary Hypertension in Experimental Congenital Diaphragmatic Hernia 2011 ·Circulation ·Christina Luong, (unknown), Arul Vadivel, (unknown), Yves Sauvé, Debby P.Y. Koonen, Don K. Walker, Kathryn G. Todd, Pierre Gressèns, Zamaneh Kassiri, (unknown), Beverly C. Morgan, Farah Eaton, Jason R.B. Dyck, Stephen L. Archer, Bernard Thébaud	115
12	Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension 2010 ·Circulation ·Stephen L. Archer, Glenn Marsboom, Gene Kim, Hannah J. Zhang, Péter T. Tóth, E. C. Svensson, Jason R.B. Dyck, Mardi Gomberg‐Maitland, Bernard Thébaud, Aliya N. Husain, Nicole A. Cipriani, Jalees Rehman	319
13	Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation 2009 ·European Respiratory Journal ·Thenappan Thenappan, Sanjiv J. Shah, Stuart Rich, Lian Tian, Stephen L. Archer, Mardi Gomberg‐Maitland	360
14	ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension breakdown → 2009 ·Circulation ·Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch, Robyn J. Barst, Harrison W. Farber, Jonathan R. Lindner, Michael A. Mathier, Michael D. McGoon, Myung H. Park, Robert S. Rosenson, Lewis J. Rubin, Victor F. Tapson, John Varga	844
15	The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted 2007 ·Proceedings of the National Academy of Sciences ·Sébastien Bonnet, Gaël Y. Rochefort, Gopinath Sutendra, Stephen L. Archer, Alois Haromy, Linda Webster, Kyoko Hashimoto, (unknown), Evangelos D. Michelakis	298
16	Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility 2007 ·Circulation ·Jayan Nagendran, Stephen L. Archer, Daniel Soliman, Vikram Gurtu, Rohit Moudgil, Alois Haromy, (unknown), Linda Webster, Ivan M. Rebeyka, David B. Ross, Peter E. Light, Jason R.B. Dyck, Evangelos D. Michelakis	394
17	A Central Role for Oxygen‐Sensitive K ⁺ Channels and Mitochondria in the Specialized Oxygen‐Sensing System 2006 ·Novartis Foundation symposium ·Stephen L. Archer, Evangelos D. Michelakis, Bernard Thébaud, Sébastien Bonnet, Rohit Moudgil, Xi‐Chen Wu, Ε. Kenneth Weir	22
18	Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension 1998 ·American Journal of Respiratory and Critical Care Medicine ·Stephen L. Archer, (unknown), Marc Humbert, Ε. Kenneth Weir, Muriel Fartoukh, J Dall'Ava-Santucci, (unknown), Gérald Simonneau, Anh Tuan Dinh‐Xuan	84
19	Developmental Changes in K^+ Channel Expression May Determine the O_2 Response of the Ductus Arteriosus (DA) 1996 ·The Keio Journal of Medicine ·Helen L. Reeve, Simona Tolarová, (unknown), Martin Tristani‐Firouzi, Stephen L. Archer	1
20	Nitrofurantoin reduces chronic hypoxic pulmonary hypertension in rats 1985 ·Federation Proceedings ·Stephen L. Archer, John W. Eaton, Elliot Chesler, E. K. Weir	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact